BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 47 found
  Current Search:  selsun: 47     

HTML
100%
Many Remedies May Rout Jock Itch
in Home Remedy Q&A Was this information helpful?

(0 votes) What do you think?

Click 'thumbs up' or 'thumbs down' to vote!

If you have more to say, post a comment below!

I have a bad case of jock itch, for want of a better word.

I've used...

Peoples Pharmacy:  Mar 16 2010 2:03AM
Matching: selsun
Find similar documents
HTML
100%
Drugmaker Sanofi-Aventis completes Chattem deal
Sanofi-Aventis said Thursday it completed its acquisition of Chattem Inc., making the Tennessee company a wholly owned subsidiary of the French drugmaker.

Sanofi-Aventis offered to buy Chattem -- which makes Gold Bond skin products, Icy Hot pain relief packs,...

AP via BusinessWeek:  Mar 11 2010 7:22PM
Matching: selsun
Find similar documents
HTML
100%
Drugmaker Sanofi-Aventis completes Chattem deal
Sanofi-Aventis said Thursday it completed its acquisition of Chattem Inc., making the Tennessee company a wholly owned subsidiary of the French drugmaker.

Sanofi-Aventis offered to buy Chattem ' which makes Gold Bond skin products, Icy Hot pain relief packs,...

Bioscience Technology Online:  Mar 11 2010 6:26PM
Matching: selsun
Find similar documents
HTML
100%
French drugmaker Sanofi-Aventis finishes acquisition of Chattem Inc.
Sanofi-Aventis said Thursday it completed its acquisition of Chattem Inc., making the Tennessee company a wholly owned subsidiary of the French drugmaker.

Sanofi-Aventis offered to buy Chattem which makes Gold Bond skin products, Icy Hot pain relief packs,...

DCExaminer.com:  Mar 11 2010 5:33PM
Matching: selsun
Find similar documents
HTML
100%
Chattem acquisition complete
Add a Comment iPod friendly version Text Size: A A A A Share/Bookmark This Page Staff Photo by Dan Henry Minnnied Hyter, left, and Cassandra Lee watch for label quality as bottles of Selsun Blue pass by at the Chattem plant.

Sanofi-Aventis has completed...

Chattanooga Times Free Press:  Mar 11 2010 5:19PM
Matching: selsun
Find similar documents
HTML
100%
Sanofis Profit Rises on Vaccine Sales
Sales of more than 100 million doses of swine flu vaccine spurred higher fourth-quarter revenue and profit for the French drug giant Sanofi-Aventis, the company said on Wednesday in a report that exceeded some analysts' expectations.

But Sanofi is still...

New York Times:  Feb 11 2010 4:53AM
Matching: selsun
Find similar documents
HTML
100%
Sanofis Profit Rises on Vaccine Sales
Sales of more than 100 million doses of swine flu vaccine spurred higher fourth-quarter revenue and profit for the French drug giant Sanofi-Aventis, the company said on Wednesday in a report that exceeded some analysts expectations.

But Sanofi is still...

New York Times:  Feb 11 2010 4:25AM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK (AP) - French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

WBOC TV 16:  Feb 10 2010 12:01PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
7:18 AM EST NEW YORK (AP) - French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8...

WTVM:  Feb 10 2010 2:57AM
Matching: selsun
Find similar documents
HTML
100%
Chattem, Inc. Gives Notice of Fundamental Change Conversion Rights to Holders of Convertible Senior Notes
CHATTANOOGA, Tenn.-- (BUSINESS WIRE) -- Chattem, Inc.

(NASDAQ: CHTT) announced that, pursuant to the terms of the indentures (the Indentures) governing its 2.00% convertible senior notes due 2013 and 1.625% convertible senior notes due 2014 (collectively, the...

SmartBrief:  Feb 10 2010 12:43AM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK (AP) - French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

Findlaw Corporate Counsel:  Feb 10 2010 12:12AM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

The Associated Press NEW YORK French drugmaker...

Seattle Times:  Feb 9 2010 12:06PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK -- French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

Rock Hill Herald:  Feb 9 2010 9:57PM
Matching: selsun
Find similar documents
HTML
100%
Chattem, Inc. Gives Notice of Fundamental Change Conversion Rights to Holders of Convertible Senior Notes
- Chattem, Inc.

(NASDAQ: CHTT) announced that, pursuant to the terms of the indentures (the Indentures) governing its 2.00% convertible senior notes due 2013 and 1.625% convertible senior notes due 2014 (collectively, the Notes), a Fundamental Change (as such...

Pharma Live:  Feb 9 2010 9:16PM
Matching: selsun
Find similar documents
HTML
100%
Chattem, Inc. Gives Notice of Fundamental Change Conversion Rights to Holders of Convertible Senior Notes
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--Chattem, Inc.

(NASDAQ: CHTT) announced that, pursuant to the terms of the indentures (the Indentures) governing its 2.00% convertible senior notes due 2013 and 1.625% convertible senior notes due 2014 (collectively, the...

Yahoo! Canada:  Feb 9 2010 6:57PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
3:59 AM NEW YORK (AP) French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8...

KTVQ.com:  Feb 9 2010 5:15PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis Completes Tender Offer for Chattem
NEW YORK (AP) -- French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

New York Times:  Feb 9 2010 4:55PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK (AP) - French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

Idaho8.com:  Feb 9 2010 3:50PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of Chattem...

Merced Sun-Star:  Feb 9 2010 3:49PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK (AP) -- French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

Record Publishing Online:  Feb 9 2010 3:18PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of Chattem shares...

Bioscience Technology Online:  Feb 9 2010 1:44PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK -- French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

Poten & Partners:  Feb 9 2010 1:38PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK - French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

Philadelphia Inquirer:  Feb 9 2010 1:23PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of Chattem...

Yahoo! Malaysia:  Feb 9 2010 1:19PM
Matching: selsun
Find similar documents
HTML
100%
Sanofi-Aventis completes tender offer for Chattem
NEW YORK (AP) - French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

Sanofi-Aventis said 89.8 percent of...

WTOP Radio:  Feb 9 2010 1:17PM
Matching: selsun
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.